Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αklotho)

Best Practice and Research: Clinical Rheumatology

Volumn 25, Issue 5, 2011, Pages 735-747

  Farrow, Emily G ^a   Imel, Erik A ^b   White, Kenneth E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

FGF 23; FGF23; GALNT3; HHS; Hyperphosphatemia; Phosphate; Tumoral calcinosis; Klotho

Indexed keywords

ACETAZOLAMIDE; ALPHA KLOTHO PROTEIN; CALCITONIN; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; N ACETYLGALACTOSAMINYLTRANSFERASE; PHOSPHATE BINDING AGENT; PROTEIN GALNT3; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR; PHOSPHATE; POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BIOLOGICAL ACTIVITY; DIET THERAPY; DRUG MECHANISM; FAMILIAL DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; HUMAN; HYPEROSTOSIS; HYPERPHOSPHATEMIA; NONHUMAN; PHOSPHATE BALANCE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RARE DISEASE; SYNDROME; TUMOR CALCINOSIS; BLOOD; CALCINOSIS; GENETICS; HYPOPHOSPHATEMIA; REVIEW;

CALCINOSIS; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HUMANS; HYPOPHOSPHATEMIA; N-ACETYLGALACTOSAMINYLTRANSFERASES; PHOSPHATES;

EID: 82955178697     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2011.10.020     Document Type: Review

References (92)

1. A.A. Portale, B.P. Halloran, and R.C. Morris Jr. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men The Journal of Clinical Investigation 83 1989 1494 1499 (Pubitemid 19124102)
2. T.J. Berndt, and F.G. Knox D.W. Seldin, G. Giebisch, The kidney: physiology and pathophysiology 1992 Raven New York pp. 2511-2532
3. P. Gmaj, and H. Murer Cellular mechanisms of inorganic phosphate transport in kidney Physiological Reviews 66 1986 36 70 (Pubitemid 16067566)
4. C.L. Mizgala, and G.A. Quamme Renal handling of phosphate Physiological Reviews 65 1985 431 466 (Pubitemid 15081129)
5. L. Beck, A.C. Karaplis, N. Amizuka, A.S. Hewson, H. Ozawa, and H.S. Tenenhouse Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities Proceedings of the National Academy of Sciences of the United States of America 95 1998 5372 5377 (Pubitemid 28208605)
6. + -phosphate cotransporter genes in murine kidney American Journal of Physiology 275 1998 F527 F534
7. H. Segawa, A. Onitsuka, M. Kuwahata, E. Hanabusa, J. Furutani, and I. Kaneko Type IIc sodium-dependent phosphate transporter regulates calcium metabolism Journal of the American Society of Nephrology 20 2009 104 113
8. C. Bergwitz, N.M. Roslin, M. Tieder, J.C. Loredo-Osti, M. Bastepe, and H. Abu-Zahra SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis The American Journal of Human Genetics 78 2006 179 192 (Pubitemid 43157559)
9. ADHR-Consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nature Genetics 26 2000 345 348
10. M. Riminucci, M.T. Collins, N.S. Fedarko, N. Cherman, A. Corsi, and K.E. White FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting The Journal of Clinical Investigation 112 2003 683 692 (Pubitemid 38057709)
11. K.E. White, G. Carn, B. Lorenz-Depiereux, A. Benet-Pages, T.M. Strom, and M.J. Econs Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23 Kidney International 60 2001 2079 2086 (Pubitemid 33070451)
12. M. Gribaa, M. Younes, Y. Bouyacoub, W. Korbaa, I. Ben Charfeddine, and M. Touzi An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation Journal of Bone and Mineral Metabolism 28 2010 111 115
13. T. Shimada, T. Muto, I. Urakawa, T. Yoneya, Y. Yamazaki, and K. Okawa Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo Endocrinology 143 2002 3179 3182 (Pubitemid 34809892)
14. J.Q. Feng, L.M. Ward, S. Liu, Y. Lu, Y. Xie, and B. Yuan Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism Nature Genetics 38 2006 1310 1315 (Pubitemid 44646294)
15. B. Lorenz-Depiereux, M. Bastepe, A. Benet-Pages, M. Amyere, J. Wagenstaller, and U. Muller-Barth DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis Nature Genetics 38 2006 1248 1250 (Pubitemid 44646286)
16. T. Saito, Y. Shimizu, M. Hori, M. Taguchi, T. Igarashi, and S. Fukumoto A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene Bone 49 2011 913 916
17. N. Weidner, and D. Santa Cruz Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets Cancer 59 1987 1442 1454 (Pubitemid 17044999)
18. T. Larsson, R. Marsell, E. Schipani, C. Ohlsson, O. Ljunggren, and H.S. Tenenhouse Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis Endocrinology 145 2004 3087 3094 (Pubitemid 38829975)
19. T. Shimada, I. Urakawa, Y. Yamazaki, H. Hasegawa, R. Hino, and T. Yoneya FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa Biochemical and Biophysical Research Communications 314 2004 409 414 (Pubitemid 38084732)
20. M.Y. Zhang, X. Wang, J.T. Wang, N.A. Compagnone, S.H. Mellon, and J.L. Olson Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule Endocrinology 143 2002 587 595 (Pubitemid 34107213)
21. X. Bai, D. Miao, J. Li, D. Goltzman, and A.C. Karaplis Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders Endocrinology 145 2004 5269 5279 (Pubitemid 39551149)
22. T. Krajisnik, P. Bjorklund, R. Marsell, O. Ljunggren, G. Akerstrom, and K.B. Jonsson Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells Journal of Endocrinology 195 2007 125 131 (Pubitemid 350056006)
23. I.Z. Ben-Dov, H. Galitzer, V. Lavi-Moshayoff, R. Goetz, M. Kuro-o, and M. Mohammadi The parathyroid is a target organ for FGF23 in rats The Journal of Clinical Investigation 117 2007 4003 4008 (Pubitemid 350224109)
24. H.J. Garringer, S.M. Mortazavi, F. Esteghamat, M. Malekpour, H. Boztepe, and R. Tanakol Two novel GALNT3 mutations in familial tumoral calcinosis American Journal of Medical Genetics 143 2007 2390 2396 (Pubitemid 47511930)
25. T. Larsson, X. Yu, S.I. Davis, M.S. Draman, S.D. Mooney, and M.J. Cullen A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis The Journal of Clinical Endocrinology and Metabolism 90 2005 2424 2427 (Pubitemid 40586293)
26. A. Benet-Pages, P. Orlik, T.M. Strom, and B. Lorenz-Depiereux An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia Human Molecular Genetics 14 2005 385 390 (Pubitemid 40220655)
27. Y. Yamazaki, R. Okazaki, M. Shibata, Y. Hasegawa, K. Satoh, and T. Tajima Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia The Journal of Clinical Endocrinology and Metabolism 87 2002 4957 4960 (Pubitemid 35316332)
28. K.B. Jonsson, R. Zahradnik, T. Larsson, K.E. White, T. Sugimoto, and Y. Imanishi Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia The New England Journal of Medicine 348 2003 1656 1663 (Pubitemid 36459471)
29. E.A. Imel, M. Peacock, P. Pitukcheewanont, H.J. Heller, L.M. Ward, and D. Shulman Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia The Journal of Clinical Endocrinology and Metabolism 91 2006 2055 2061 (Pubitemid 43854981)
30. K. Araya, S. Fukumoto, R. Backenroth, Y. Takeuchi, K. Nakayama, and N. Ito A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis The Journal of Clinical Endocrinology and Metabolism 90 2005 5523 5527 (Pubitemid 41415453)
31. T. Larsson, S.I. Davis, H.J. Garringer, S.D. Mooney, M.S. Draman, and M.J. Cullen Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed Endocrinology 146 2005 3883 3891 (Pubitemid 41178968)
32. T. Shimada, M. Kakitani, Y. Yamazaki, H. Hasegawa, Y. Takeuchi, and T. Fujita Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism The Journal of Clinical Investigation 113 2004 561 568 (Pubitemid 38542505)
33. D. Sitara, M.S. Razzaque, M. Hesse, S. Yoganathan, T. Taguchi, and R.G. Erben Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice Matrix Biology 23 2004 421 432 (Pubitemid 39576657)
34. O. Topaz, D.L. Shurman, R. Bergman, M. Indelman, P. Ratajczak, and M. Mizrachi Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis Nature Genetics 36 2004 579 581 (Pubitemid 38715983)
35. H.J. Garringer, C. Fisher, T.E. Larsson, S.I. Davis, D.L. Koller, and M.J. Cullen The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis The Journal of Clinical Endocrinology and Metabolism 91 2006 4037 4042 (Pubitemid 44536883)
36. K. Kato, C. Jeanneau, M.A. Tarp, A. Benet-Pages, B. Lorenz-Depiereux, and E.P. Bennett Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. secretion of fibroblast growth factor 23 requires O-glycosylation The Journal of Biological Chemistry 281 2006 18370 18377 (Pubitemid 44035494)
37. S. Ichikawa, E.A. Imel, A.H. Sorenson, R. Severe, P. Knudson, and G.J. Harris Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene The Journal of Clinical Endocrinology and Metabolism 91 2006 4472 4475 (Pubitemid 44833425)
38. Y. Frishberg, N. Ito, C. Rinat, Y. Yamazaki, S. Feinstein, and I. Urakawa Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23 Journal of Bone and Mineral Research 22 2007 235 242 (Pubitemid 46167794)
39. S. Ichikawa, A.H. Sorenson, A.M. Austin, D.S. Mackenzie, T.A. Fritz, and A. Moh Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression Endocrinology 150 2009 2543 2550
40. T. Larsson, U. Nisbeth, O. Ljunggren, H. Juppner, and K.B. Jonsson Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers Kidney International 64 2003 2272 2279 (Pubitemid 37449564)
41. S.L. Ferrari, J.P. Bonjour, and R. Rizzoli Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men The Journal of Clinical Endocrinology and Metabolism 90 2005 1519 1524 (Pubitemid 40464013)
42. S.M. Burnett, S.C. Gunawardene, F.R. Bringhurst, H. Juppner, H. Lee, and J.S. Finkelstein Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women Journal of Bone and Mineral Research 21 2006 1187 1196 (Pubitemid 44128331)
43. X. Yu, Y. Sabbagh, S.I. Davis, M.B. Demay, and K.E. White Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations Bone 36 2005 971 977 (Pubitemid 40797997)
44. M. Ito, Y. Sakai, M. Furumoto, H. Segawa, S. Haito, and S. Yamanaka Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells American Journal of Physiology-Endocrinology and Metabolism 288 2005 E1101 E1109
45. T. Shimada, H. Hasegawa, Y. Yamazaki, T. Muto, R. Hino, and Y. Takeuchi FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis Journal of Bone and Mineral Research 19 2004 429 435 (Pubitemid 38787398)
46. O.I. Kolek, E.R. Hines, M.D. Jones, L.K. LeSueur, M.A. Lipko, and P.R. Kiela 1alpha,25-dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport American Journal of Physiology-Gastrointestinal and Liver Physiology 289 2005 G1036 G1042
47. C. Bergwitz, S. Banerjee, H. Abu-Zahra, H. Kaji, A. Miyauchi, and T. Sugimoto Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis The Journal of Clinical Endocrinology and Metabolism 94 2009 4267 4274
48. D.M. Ornitz, and N. Itoh Fibroblast growth factors Genome Biology 2 2001 1 12
49. H. Kurosu, M. Choi, Y. Ogawa, A.S. Dickson, R. Goetz, and A.V. Eliseenkova Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 The Journal of Biological Chemistry 282 2007 26687 26695 (Pubitemid 47501965)
50. S.A. Li, M. Watanabe, H. Yamada, A. Nagai, M. Kinuta, and K. Takei Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice Cell Structure and Function 29 2004 91 99 (Pubitemid 40260033)
51. M. Kuro-o, Y. Matsumura, H. Aizawa, H. Kawaguchi, T. Suga, and T. Utsugi Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 1997 45 51 (Pubitemid 27494749)
52. Y. Matsumura, H. Aizawa, T. Shiraki-Iida, R. Nagai, M. Kuro-o, and Y. Nabeshima Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein Biochemical and Biophysical Research Communications 242 1998 626 630 (Pubitemid 28412578)
53. T. Shiraki-Iida, H. Aizawa, Y. Matsumura, S. Sekine, A. Iida, and H. Anazawa Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein FEBS Letters 424 1998 6 10 (Pubitemid 28130341)
54. H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi, and K.P. Rosenblatt Regulation of fibroblast growth factor-23 signaling by klotho The Journal of Biological Chemistry 281 2006 6120 6123 (Pubitemid 43847540)
55. E.G. Farrow, L.J. Summers, S.C. Schiavi, J.A. McCormick, D.H. Ellison, and K.E. White Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation The Journal of Endocrinology 207 2010 67 75
56. I. Urakawa, Y. Yamazaki, T. Shimada, K. Iijima, H. Hasegawa, and K. Okawa Klotho converts canonical FGF receptor into a specific receptor for FGF23 Nature 444 7120 2006 770 774 (Pubitemid 44949607)
57. H. Li, A. Martin, V. David, and L.D. Quarles Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype American Journal of Physiology Endocrinology and Metabolism 300 2011 E508 E517
58. T. Shimada, S. Mizutani, T. Muto, T. Yoneya, R. Hino, and S. Takeda Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Proceedings of the National Academy of Sciences of the United States of America 98 2001 6500 6505 (Pubitemid 32488266)
59. S. Ichikawa, E.A. Imel, M.L. Kreiter, X. Yu, D.S. Mackenzie, and A.H. Sorenson A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis The Journal of Clinical Investigation 117 2007 2684 2691 (Pubitemid 47494368)
60. Y. Nabeshima Ectopic calcification in Klotho mice Clinical Calcium 12 2002 1114 1117
61. H. Tsujikawa, Y. Kurotaki, T. Fujimori, K. Fukuda, and Y. Nabeshima Klotho a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system Molecular Endocrinology (Baltimore, Md) 17 2003 2393 2403 (Pubitemid 37542205)
62. M.A. Mikati, R.E. Melhem, and S.S. Najjar The syndrome of hyperostosis and hyperphosphatemia The Journal of Pediatrics 99 1981 900 904 (Pubitemid 12240111)
63. Y. Frishberg, O. Topaz, R. Bergman, D. Behar, D. Fisher, and D. Gordon Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders Journal of Molecular Medicine 83 2005 33 38 (Pubitemid 40169494)
64. S. Ichikawa, G. Baujat, A. Seyahi, A.G. Garoufali, E.A. Imel, and L.R. Padgett Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations American Journal of Medical Genetics. Part A 152A 2010 896 903
65. F.W. Lafferty, E.S. Reynolds, and O.H. Pearson Tumoral calcinosis: A metabolic disease of obscure etiology The American Journal of Medicine 38 1965 105 118
66. A. Yancovitch, D. Hershkovitz, M. Indelman, P. Galloway, M. Whiteford, and E. Sprecher Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis Journal of Bone and Mineral Metabolism 29 2011 621 625
67. R. Dhingra, L.M. Sullivan, C.S. Fox, T.J. Wang, R.B. D'Agostino Sr., and J.M. Gaziano Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community Archives of Internal Medicine 167 2007 879 885 (Pubitemid 46762749)
68. O.M. Gutierrez, M. Mannstadt, T. Isakova, J.A. Rauh-Hain, H. Tamez, and A. Shah Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis The New England Journal of Medicine 359 2008 584 592
69. M. Tonelli, F. Sacks, M. Pfeffer, Z. Gao, and G. Curhan Relation between serum phosphate level and cardiovascular event rate in people with coronary disease Circulation 112 2005 2627 2633 (Pubitemid 41532599)
70. J.R. Stubbs, S. Liu, W. Tang, J. Zhou, Y. Wang, and X. Yao Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice Journal of the American Society of Nephrology 18 2007 2116 2124 (Pubitemid 47041077)
71. A. Gregosiewicz, and E. Warda Tumoral calcinosis: successful medical treatment. a case report The Journal of Bone and Joint Surgery American Volume 71 1989 1244 1249 (Pubitemid 19262375)
72. E.G. Lufkin, R. Kumar, and H. Heath 3rd Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action The Journal of Clinical Endocrinology and Metabolism 56 1983 1319 1322 (Pubitemid 13055133)
73. E.G. Lufkin, D.M. Wilson, L.H. Smith, N.J. Bill, H.F. DeLuca, and T.P. Dousa Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide The Journal of Clinical Endocrinology and Metabolism 50 1980 648 653 (Pubitemid 10009126)
74. G. Mozaffarian, M.K. Nakhjavani, M.H. Hedayati, and S. Shamekh Phosphorus deprivation treatment of tumoral calcinosis Annals of Internal Medicine 86 1977 120
75. A.Z. Alkhooly Medical treatment for tumoral calcinosis with eight years of follow-up: a report of four cases Journal of Orthopaedic Surgery (Hong Kong) 17 2009 379 382
76. M.C. Janssen, and R.G. de Sevaux Tumoral calcinosis Journal of Inherited Metabolic Disease 33 2010 91 92
77. G. Mozaffarian, F.W. Lafferty, and O.H. Pearson Treatment of tumoral calcinosis with phosphorus deprivation Annals of Internal Medicine 77 1972 741 745
78. T. Yamaguchi, T. Sugimoto, Y. Imai, M. Fukase, T. Fujita, and K. Chihara Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide Bone 16 1995 247S 250S
79. C. Alves, and R. Lima Hyperphosphatemic tumoral calcinosis: a 10-year follow-up Journal of Pediatric Endocrinology and Metabolism 24 2011 25 27
80. M.F. Campagnoli, A. Pucci, E. Garelli, A. Carando, C. Defilippi, and R. Lala Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family Journal of Clinical Pathology 59 2006 440 442
81. F.G. Knox, J.A. Haas, and C.P. Lechene Effect of parathyroid hormone on phosphate reabsorption in the presence of acetazolamide Kidney International 10 1976 216 220
82. T.K. Sinha, D.O. Allen, S.F. Queener, N.H. Bell, S. Larson, and R. McClintock Effects of acetazolamide on the renal excretion of phosphate in hypoparathyroidism and pseudohypoparathyroidism The Journal of Laboratory and Clinical Medicine 89 1977 1188 1197 (Pubitemid 8130191)
83. R. Candrina, B. Cerudelli, V. Braga, and A. Salvi Effects of the acute subcutaneous administration of synthetic salmon calcitonin in tumoral calcinosis Journal of Endocrinological Investigation 12 1989 55 57 (Pubitemid 19060732)
84. A. Salvi, B. Cerudelli, A. Cimino, F. Zuccato, and G. Giustina Phosphaturic action of calcitonin in pseudotumoral calcinosis Hormone and Metabolic Research 15 1983 260 (Pubitemid 13092299)
85. J.C. Kallmeyer, L.P. Seimon, and E.T. MacSearraigh The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis South African Medical Journal 54 1978 963 966
86. M.J. Econs, B. Lobaugh, and M.K. Drezner Normal calcitonin stimulation of serum calcitriol in patients with X-linked hypophosphatemic rickets Journal of Clinical Endocrinology and Metabolism 75 1992 408 411
87. E.S. Liu, T.O. Carpenter, C.M. Gundberg, C.A. Simpson, and K.L. Insogna Calcitonin administration in X-linked hypophosphatemia The New England Journal of Medicine 364 2011 1678 1680
88. G.R. Ambler, J. Chaitow, M. Rogers, D.W. McDonald, and R.A. Ouvrier Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy The Journal of Rheumatology 32 2005 1837 1839 (Pubitemid 41324828)
89. A. Marco Puche, I. Calvo Penades, and B. Lopez Montesinos Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis Clinical and Experimental Rheumatology 28 2010 135 140
90. S. Slimani, A. Abdessemed, A. Haddouche, and A. Ladjouze-Rezig Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate Joint Bone Spine 77 2010 70 72
91. I. Hug, and J. Guncaga Tumoral calcinosis with sedimentation sign The British Journal of Radiology 47 1974 734 736
92. E. Leicht, H.J. Tkocz, H. Seeliger, T. Lauffenburger, and H.G. Haas Tumoral calcinosis. observations during six years Hormone and Metabolic Research 12 1980 269 273 (Pubitemid 10123148)